Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

Eric S. Orwoll, Paul D. Miller, Jonathan D. Adachi, Jacques Brown, Robert A. Adler, David Kendler, Christina Bucci-Rechtweg, Aimee Readie, Peter Mesenbrink, Robert S. Weinstein

Research output: Contribution to journal › Article › peer-review

143 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences